The prevalence of metabolic syndrome among US women of childbearing age

American Journal of Public Health

Volumn 98, Issue 6, 2008, Pages 1122-1127

  Ramos, Rosemarie G ^a   Olden, Kenneth ^a  

^a NH 278 ^*

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL LIPASE;

ADULT; ARTICLE; DIABETES MELLITUS; ETHNIC DIFFERENCE; FEMALE; GLUCOSE BLOOD LEVEL; HISPANIC; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; PREVALENCE; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES; WOMEN'S HEALTH;

ADOLESCENT; ADULT; FEMALE; HUMANS; LOGISTIC MODELS; METABOLIC SYNDROME X; NUTRITION SURVEYS; PHENOTYPE; PREVALENCE; RISK FACTORS; UNITED STATES;

EID: 44849100856     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2007.120055     Document Type: Article

References (45)

1. National Heart Lung and Blood Institute, National Institutes of Health. Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Available at: http://www.nhlbi.nih.gov/guidelines/ cholesterol/atp3full.pdf. Accessed May 12, 2007.
2. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112:2735-2752.
3. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among US adults. Diabetes Care. 2004;27(10):2444-2449.
4. National Institutes of Health. Strategic plan for NIH obesity research. A report of the NIH Obesity Research Task Force. Available at: http://www.obesityresearch.nih.gov/about/strategic-plan.htm. Accessed March 20, 2007.
5. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-359.
6. Braunschweig CL, Gomez S, Liang H, et al. Obesity and risk factors for the metabolic syndrome among low-income, urban, African American schoolchildren: the rule rather than the exception? Am J Clin Nutr. 2005;81:970-975.
7. Meigs JB, Wilson PW, Nathan DM, D'Agostino RB Sr, Williams K, Haffner SM. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes. 2003;52:2160-2167.
8. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2003;163:427-436.
9. Lundberg V, Stegmayr B, Asplund K, Eliasson M, Huhtasaari F. Diabetes as a risk factor for myocardial infarction: population and gender perspectives. J Intern Med. 1997;241:485-492.
10. de Zegher F, Ibanez L. Prenatal growth restraint followed by catch-up of weight: a hyperinsulinemic pathway to polycystic ovary syndrome. Fertil Steril. 2006;86 (suppl 1):S4-S5.
11. Taylor PD, Poston L. Developmental programming of obesity in mammals. Exp Physiol. 2007;92:287-298.
12. Weaver LT. Rapid growth in infancy: balancing the interests of the child. J Pediatr Gastroenterol Nutr. 2006;43:428-432.
13. Bo S, Menato G, Signorile A, et al. Obesity or diabetes: what is worse for the mother and for the baby? Diabetes Metab. 2003;29(2 Pt 1):175-178.
14. Stocker CJ, Arch JR, Cawthorne MA. Fetal origins of insulin resistance and obesity. Proc Nutr Soc. 2005;64:143-151.
15. Valsamakis G, Kanaka-Gantenbein C, Malamitsi-Puchner A, Mastorakos G. Causes of intrauterine growth restriction and the postnatal development of the metabolic syndrome. Ann N Y Acad Sci. 2006;1092:138-147.
16. National Center for Health Statistics, Centers for Disease Control and Prevention. The Third National Health and Nutrition Examination Survey (NHANES III 1988-94) reference manuals and reports. Available at: http://www.cdc.gov/ nchs/products/elec_prods/subject/nhanes3.htm. Accessed May 16, 2007.
17. Centers for Disease Control and Prevention, National Center for Health Statistics. NHANES 2003-2004. Available at: http://www.cdc.gov/nchs/about/major/ nhanes/nhanes2003-2004/lab_methods_03_04.htm. Accessed January 24, 2008.
18. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med. 2006;23:469-480.
19. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr Opin Cardiol. 2006;21:1-6.
20. National Center for Health Statistics. Healthy People 2000, Final Review. Hyattsville, MD: Public Health Service; 2001.
21. Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics. 2005;115(3):e290-e296.
22. Whitaker RC, Pepe MS, Seidel KD, Wright JA, Knopp RH. Gestational diabetes and the risk of offspring obesity. Pediatrics. 1998;101(2):E9.
23. Nilsson PM, Nilsson JA, Berglund G. Family burden of cardiovascular mortality: risk implications for offspring in a national register linkage study based upon the Malmo Preventive Project. J Intern Med. 2004;255:229-235.
24. Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics - 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115(4):e69-e171.
25. Kim C, Beckles GL. Cardiovascular disease risk reduction in the Behavioral Risk Factor Surveillance System. Am J Prev Med. 2004;27:1-7.
26. Orio F Jr, Palomba S, Cascella T, Savastano S, Lombardi G, Colao A. Cardiovascular complications of obesity in adolescents. J Endocrinol Invest. 2007;30:70-80.
27. Ford ES, Mokdad AH, Giles WH. Trends in waist circumference among US adults. Obes Res. 2003;11:1223-1231.
28. Hillege HL, Fidler V, Diercks GF, et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation. 2002;106:1777-1782.
29. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683-689.
30. Meigs JB, D'Agostino RB Sr, Wilson PW, Cupples LA, Nathan DM, Singer DE. Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes. 1997;46:1594-1600.
31. Natali A, Toschi E, Baldeweg S, et al. Clustering of insulin resistance with vascular dysfunction and lowgrade inflammation in type 2 diabetes. Diabetes. 2006;55:1133-1140.
32. Bo S, Ciccone G, Pearce N, et al. Prevalence of undiagnosed metabolic syndrome in a population of adult asymptomatic subjects. Diabetes Res Clin Pract. 2007;75:362-365.
33. de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation. 2004;110:2494-2497.
34. Committee on the Impact of Pregnancy Weight on Maternal and Child Health, National Research Council. Influence of Pregnancy Weight on Maternal and Child Health: Workshop Report. Available at: http://www.nap.edu/catalog.php? record_id=11817. Accessed May 10, 2007.
35. Johnson K, Posner SF, Biermann J, et al. Recommendations to improve preconception health and health care - United States. A report of the CDC/ATSDR Preconception Care Work Group and the Select Panel on Preconception Care. Available at: http://www.cdc.gov/mmwR/preview/mmwrhtml/rr5506a1.htm. Accessed February 5, 2007.
36. Gill H, Mugo M, Whaley-Connell A, Stump C, Sowers JR. The key role of insulin resistance in the cardiometabolic syndrome. Am J Med Sci. 2005;330:290-294.
37. Grundy SM. Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab. 2004;89:2595-2600.
38. Foy CG, Foley KL, D'Agostino RB Jr, Goff DC Jr, Mayer-Davis E, Wagenknecht LE. Physical activity, insulin sensitivity, and hypertension among US adults: findings from the Insulin Resistance Atherosclerosis Study. Am J Epidemiol. 2006;163:921-928.
39. Straznicky NE, Lambert EA, Lambert GW, Masuo K, Esler MD, Nestel PJ. Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome. J Clin Endocrinol Metab. 2005;90:5998-6005.
40. de Ferranti SD, Gauvreau K, Ludwig DS, Newburger JW, Rifai N. Inflammation and changes in metabolic syndrome abnormalities in US adolescents: findings from the 1988-1994 and 1999-2000 National Health and Nutrition Examination Surveys. Clin Chem. 2006;52(7):1325-1330.
41. Ford ES, Ajani UA, Mokdad AH. The metabolic syndrome and concentrations of C-reactive protein among US youth. Diabetes Care. 2005;28:878-881.
42. Organisation of Economic Co-Operation and Development. OECD health data 2005 - how does the United States compare? Available at: http://www.oecd.org/ dataoecd/15/23/34970246.pdf. Accessed January 24, 2008.
43. Ford ES, Giles WH, Mokdad AH. Family history of diabetes or cardiovascular disease and C-reactive protein concentration: findings from the National Health and Nutrition Examination Survey, 1999-2000. Am J Prev Med. 2005;29(5 suppl 1):57-62.
44. Diamanti-Kandarakis E, Christakou C, Kandarakis H. Polycystic ovarian syndrome: the commonest cause of hyperandrogenemia in women as a risk factor for metabolic syndrome. Minerva Endocrinol. 2007;32:35-47.
45. Patel SM, Nestler JE. Fertility in polycystic ovary syndrome. Endocrinol Metab Clin North Am. 2006;35(1):vii, 137-155.